FOLH1 and neoplasm: For instance, LAVA-1207 is a bispecific TCE that, instead of a pan-T-cell CD3-binding arm, employs one arm to directly bind the Vgamma9 Vdelta2 T-cell receptor (Vγ9Vδ2 TCR), thereby selectively engaging this particular subset of gamma delta T-cells for PSMA-targeted tumor cell lysis [30].